HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.

AuthorsM Tuffigo, E Lazaro, C James, C Subtil, J-F Viallard, M Fiore
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 21 Issue 1 Pg. e116-8 (Jan 2015) ISSN: 1365-2516 [Electronic] England
PMID25471665 (Publication Type: Case Reports, Letter)
Chemical References
  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Factor VIIa (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic (complications)
  • Recombinant Proteins (administration & dosage, therapeutic use)
  • Thrombasthenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: